Back to Search
Start Over
Immunovia seeks US patent to protect its next-generation test to detect stage 1 & 2 pancreatic cancer
- Source :
- PharmaBiz. August 5, 2024
- Publication Year :
- 2024
-
Abstract
- Immunovia, the pancreatic cancer diagnostics company, announces the company has filed a US provisional patent application to protect the intellectual property embodied in its next-generation test to detect stage 1 [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.803796481